Literature DB >> 2544218

Expression of the small cell carcinoma antigens of cluster-5 and cluster-5A in primary lung tumours.

A Maier1, U Schmidt, R Waibel, W Hartung, R A Stahel.   

Abstract

The expression of the small cell carcinoma (SCLC) antigens cluster-5 (antibody LAM8) and cluster-5A (antibody SWA20) was examined on a panel of routinely processed biopsy or surgical specimens of 290 lung tumours by immunoperoxidase staining. Antigen expression was largely restricted to SCLC. Of over 150 tissue samples evaluated, moderate or strong antigen expression was found in 49% (cluster-5) and 45% (cluster-5A). Concordance in expression of the two antigens was seen in 71% of SCLC samples, with 35% expressing both antigens strongly, 8% moderately and 28% being negative for both antigens. Antigen expression was independent of the morphological subtype of SCLC. Primary lung tumours of other histology, including squamous cell carcinoma, large cell carcinoma, adenocarcinoma, mesothelioma or carcinoid had no significant antigen expression. Of 135 tumours, strong or moderate expression of both antigens was seen only in two cases. 20%, mostly carcinoids, were weakly positive for cluster 5 and 4% for cluster 5A antigen. The remainder were antigen negative. No significant antigen expression was seen in 25 normal lung tissues. The membrane antigens of SCLC cluster 5 and 5A are markers for SCLC and their expression in tissues is tumour-associated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544218      PMCID: PMC2247226          DOI: 10.1038/bjc.1989.144

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  FIGO/WHO Workshop on Innovative Approaches to Maternal and Neonatal Care As Part of Primary Health Care, Tokyo, 22-24 October, 1979.

Authors: 
Journal:  Malays J Reprod Health       Date:  1984-12

2.  Characterization of an epithelial and a tumor-associated human small cell lung carcinoma glycoprotein antigen.

Authors:  R Waibel; C J O'Hara; R A Stahel
Journal:  Cancer Res       Date:  1987-07-15       Impact factor: 12.701

3.  Murine monoclonal antibody LAM2 defines cell membrane determinant with preferential expression on human lung small-cell carcinoma and squamous-cell carcinomas.

Authors:  R A Stahel; J A Speak; S D Bernal
Journal:  Int J Cancer       Date:  1985-01-15       Impact factor: 7.396

4.  Antigens of small-cell lung cancer. First International Workshop.

Authors:  R L Souhami; P C Beverley; L G Bobrow
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

5.  Tumor-associated membrane sialoglycoprotein on human small cell lung carcinoma identified by the IgG2a monoclonal antibody SWA20.

Authors:  R Waibel; C J O'Hara; A Smith; R A Stahel
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

6.  Neuroendocrine differentiation antigen on human lung carcinoma and Kulchitski cells.

Authors:  L de Leij; S Poppema; J K Nulend; A ter Haar; E Schwander; F Ebbens; P E Postmus; T H The
Journal:  Cancer Res       Date:  1985-05       Impact factor: 12.701

7.  Monoclonal antibody that distinguishes small-cell lung cancer from non-small-cell lung cancer.

Authors:  J Watanabe; T Okabe; M Fujisawa; F Takaku; S Hirohashi; Y Shimosato
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

8.  Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35.

Authors:  T Takahashi; R Ueda; X Song; K Nishida; M Shinzato; R Namikawa; Y Ariyoshi; K Ota; K Kato; T Nagatsu
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

9.  HNK-1-defined antigen detected in paraffin-embedded neuroectoderm tumors and those derived from cells of the amine precursor uptake and decarboxylation system.

Authors:  J M Caillaud; S Benjelloun; J Bosq; K Braham; M Lipinski
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

10.  A unique cell-surface protein phenotype distinguishes human small-cell from non-small-cell lung cancer.

Authors:  S B Baylin; A F Gazdar; J D Minna; S D Bernal; J H Shaper
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

View more
  5 in total

1.  Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer.

Authors:  E J Derbyshire; R A Stahel; E J Wawrzynczak
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Monoclonal antibodies defining the cluster-5A small cell lung carcinoma antigen.

Authors:  R Waibel; C J O'Hara; R A Stahel
Journal:  Br J Cancer Suppl       Date:  1991-06

3.  Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.

Authors:  E J Wawrzynczak; E J Derbyshire; R V Henry; G D Parnell; A Smith; R Waibel; R A Stahel
Journal:  Br J Cancer Suppl       Date:  1991-06

4.  Results of the central data analysis.

Authors:  P C Beverley; Y Olabiran; J A Ledermann; L G Bobrow; R L Souhami
Journal:  Br J Cancer Suppl       Date:  1991-06

5.  Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen.

Authors:  E J Wawrzynczak; E J Derbyshire; R V Henry; G D Parnell; A Smith; R Waibel; R A Stahel
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.